Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Better Pharmaceutical is a leading Chinese pharmaceutical manufacturer and a core subsidiary of the Better Pharmaceutical Group. Located in the Haikou National High-tech Zone, the company focuses on the production of high-end generic drugs and active pharmaceutical ingredients (APIs). Its extensive portfolio includes anti-infectives, cardiovascular treatments, and respiratory medications, with a particular strength in cephalosporin antibiotics. The company maintains advanced GMP-certified facilities and is a key player in China's pharmaceutical supply chain, exporting products to various international markets. Hainan Better Pharmaceutical is recognized for its integration of R&D and large-scale manufacturing, supporting the group's mission to provide affordable, high-quality healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Better Pharmaceutical.